Cognitive and metabolic outcomes of vildagliptin addition to the therapy in patients with type 2 diabetes mellitus: 26 week follow-up study
Esra Ateş Bulut, Zehra Yağmur Şahin Alak, Özge Dokuzlar, Süleyman Emre Koçyiğit, Pınar Soysal, Lee Smith, Ahmet Turan Işık
Topics & Concepts
VildagliptinMedicineType 2 Diabetes MellitusDiabetes mellitusInternal medicineType 2 diabetesDementiaMetabolic control analysisCognitive declineHypoglycemiaEndocrinologyDiseaseDiabetes Treatment and ManagementPeptidase Inhibition and AnalysisBariatric Surgery and Outcomes